SEC Form D · filed April 10, 2024
Immunomic Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Dong-Gun Kim · ROCKVILLE, MDExec · DirectorKi-Hong E. Ahn · ROCKVILLE, MDDirectorJames W. Wishart · ROCKVILLE, MDDirectorRobert E. Ahlgren · ROCKVILLE, MDDirectorMatthew E. Chang · ROCKVILLE, MDDirectorMichael D. Lack · ROCKVILLE, MDDirectorC. E. Winzer · ROCKVILLE, MDExecRonald P. Thiboutot · ROCKVILLE, MDDirectorSteve E. Park · ROCKVILLE, MDDirectorYang Gon E. Jin · ROCKVILLE, MDDirectorRobert E. Ahlgren · ROCKVILLE, MDDirectorNoah Gottdiener · New York, NYDirectorKi-Hong E. Ahn · ROCKVILLE, MDDirectorMatthew E. Chang · ROCKVILLE, MDDirectorEdward W. Forman · New York, NYExecSteve E. Park · ROCKVILLE, MDDirectorJacob Silverman · New York, NYDirectorYang Gon E. Jin · ROCKVILLE, MDDirectorPatrick Puzzuoli · New York, NYDirectorDong-Gun Kim · ROCKVILLE, MDExec · DirectorLeise N. Rosman · Phoenix, AZDirectorKris N. Krane · Phoenix, AZExecKarl N. Chowscano · Phoenix, AZDirectorEric A. Naison-Phillips · New York, NYDirectorPeter Jonna · San Diego, CAExec · DirectorChristiian Marriott · London, United KingdomDirectorStorage Units Capital Management II Corporation · Maitland, FLDirectorStorage Units Ground Lease Management Corporation · Maitland, FLDirectorFarooq Cheema · Virginia Beach, VADirectorMarion D. Broch · Luxembourg, LuxembourgDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗